Fasting Study of Divalproex Sodium Extended-Release Tablets 500 mg to Depakote ER® Tablets 500 mg

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2004
The objective of this study was to investigate the bioequivalence of Mylan\'s divalproex sodium 500 mg extended-release tablets to Abbott\'s Depakote ER® 500 mg tablets following a single, oral 500 mg (1 x 500 mg) dose administered under fasting conditions.
Epistemonikos ID: 64095c5b4fa6e079aaf313237d2a34bcf49ccc5c
First added on: May 04, 2024